All Stories

  1. Antistaphylococcal Activity of Oritavancin and Its Synergistic Effect in Combination with Other Antimicrobial Agents

    Article • Antimicrobial Agents and Chemotherapy, July 2014, ASM Journals

    Dr Klaudia Kosowska-Shick

  2. Activity of telavancin compared to other agents against coagulase-negative staphylococci with different resistotypes by time kill

    Article • Diagnostic Microbiology and Infectious Disease, July 2012, Elsevier

    Dr Klaudia Kosowska-Shick

  3. Characterization of methicillin-resistant Staphylococcus aureus displaying increased MICs of ceftaroline

    Article • Journal of Antimicrobial Chemotherapy, March 2012, Oxford University Press (OUP)

    Dr Klaudia Kosowska-Shick

  4. Multistep Resistance Development Studies of Ceftaroline in Gram-Positive and -Negative Bacteria

    Article • Antimicrobial Agents and Chemotherapy, February 2011, ASM Journals

    Dr Klaudia Kosowska-Shick

  5. In VitroActivity of Fusidic Acid (CEM-102, Sodium Fusidate) against Staphylococcus aureus Isolates from Cystic Fibrosis Patients and Its Effect on the Activities of Tobramycin and Amikacin against Pseudomonas aeruginosa and Burkholderia cepacia

    Article • Antimicrobial Agents and Chemotherapy, February 2011, ASM Journals

    Dr Klaudia Kosowska-Shick

  6. Activity of ACHN-490 Tested Alone and in Combination with Other Agents against Pseudomonas aeruginosa

    Article • Antimicrobial Agents and Chemotherapy, January 2011, ASM Journals

    Dr Klaudia Kosowska-Shick

  7. Activity of moxifloxacin against intracellular community-acquired methicillin-resistant Staphylococcus aureus: comparison with clindamycin, linezolid and co-trimoxazole and attempt at defining an intracellular susceptibility breakpoint

    Article • Journal of Antimicrobial Chemotherapy, December 2010, Oxford University Press (OUP)

    Dr Klaudia Kosowska-Shick, Professor Françoise Van Bambeke

  8. Molecular and epidemiologic characteristics of linezolid-resistant coagulase-negative staphylococci at a tertiary care hospital

    Article • Diagnostic Microbiology and Infectious Disease, September 2010, Elsevier

    Dr Klaudia Kosowska-Shick

  9. Cellular Pharmacodynamics of the Novel Biaryloxazolidinone Radezolid: Studies with Infected Phagocytic and Nonphagocytic cells, Using Staphylococcus aureus, Staphylococcus epidermidis, Listeria monocytogenes, and Legionella pneumophila

    Article • Antimicrobial Agents and Chemotherapy, April 2010, ASM Journals

    Dr Klaudia Kosowska-Shick, Professor Françoise Van Bambeke

  10. Mutant Prevention Concentrations of Four Carbapenems against Gram-Negative Rods

    Article • Antimicrobial Agents and Chemotherapy, March 2010, ASM Journals

    Dr Klaudia Kosowska-Shick

  11. Affinity of Ceftaroline and Other  -Lactams for Penicillin-Binding Proteins from Staphylococcus aureus and Streptococcus pneumoniae

    Article • Antimicrobial Agents and Chemotherapy, March 2010, ASM Journals

    Dr Klaudia Kosowska-Shick

  12. Comparative Study of the Mutant Prevention Concentrations of Moxifloxacin, Levofloxacin, and Gemifloxacin against Pneumococci

    Article • Antimicrobial Agents and Chemotherapy, December 2009, ASM Journals

    Dr Klaudia Kosowska-Shick

  13. In Vitro Activity of CEM-101 against Streptococcus pneumoniae and Streptococcus pyogenes with Defined Macrolide Resistance Mechanisms

    Article • Antimicrobial Agents and Chemotherapy, November 2009, ASM Journals

    Dr Klaudia Kosowska-Shick

  14. Activity of Telavancin against Staphylococci and Enterococci Determined by MIC and Resistance Selection Studies

    Article • Antimicrobial Agents and Chemotherapy, July 2009, ASM Journals

    Dr Klaudia Kosowska-Shick

  15. O31 Radezolid (RX-1741), a novel oxazolidinone, accumulates extensively within human macrophages and PMNs and shows activity towards intracellular linezolid-sensitive and linezolid-resistant Staphylococcus aureus

    Article • International Journal of Antimicrobial Agents, July 2009, Elsevier

    Dr Klaudia Kosowska-Shick, Professor Françoise Van Bambeke

  16. Resistance Selection Studies Comparing the Activity of Razupenem (PTZ601) to Vancomycin and Linezolid against Eight Methicillin-Resistant and Two Methicillin-Susceptible Staphylococcus aureus Strains

    Article • Antimicrobial Agents and Chemotherapy, May 2009, ASM Journals

    Dr Klaudia Kosowska-Shick

  17. Comparative Antipneumococcal Activities of Sulopenem and Other Drugs

    Article • Antimicrobial Agents and Chemotherapy, March 2009, ASM Journals

    Dr Klaudia Kosowska-Shick

  18. In Vitro Activity of the Quinolone WCK 771 against Recent U.S. Hospital and Community-Acquired Staphylococcus aureus Pathogens with Various Resistance Types

    Article • Antimicrobial Agents and Chemotherapy, March 2009, ASM Journals

    Dr Klaudia Kosowska-Shick

  19. Binding of Faropenem and Other β-Lactam Agents to Penicillin-Binding Proteins of Pneumococci with Various β-Lactam Susceptibilities

    Article • Antimicrobial Agents and Chemotherapy, February 2009, ASM Journals

    Dr Klaudia Kosowska-Shick

  20. Antistaphylococcal Activity of Dihydrophthalazine Antifolates, a Family of Novel Antibacterial Drugs

    Article • Antimicrobial Agents and Chemotherapy, February 2009, ASM Journals

    Dr Klaudia Kosowska-Shick

  21. In Vitro Activity of the Quinolone WCK 771 against Recent U.S. Hospital and Community-Acquired Staphylococcus aureus Pathogens with Various Resistance Types

    Article • Antimicrobial Agents and Chemotherapy, November 2008, ASM Journals

    Dr Klaudia Kosowska-Shick

  22. Incidence and Characteristics of Vancomycin Nonsusceptible Strains of Methicillin-Resistant Staphylococcus aureus at Hershey Medical Center

    Article • Antimicrobial Agents and Chemotherapy, October 2008, ASM Journals

    Dr Klaudia Kosowska-Shick

  23. Genotypes of macrolide-resistant pneumococci from children in southwestern Japan: raised incidence of strains that have both erm(B) and mef(A) with serotype 6B clones

    Article • Diagnostic Microbiology and Infectious Disease, September 2008, Elsevier

    Dr Klaudia Kosowska-Shick

  24. Activities of antistaphylococcal antibiotics towards the extracellular and intraphagocytic forms of Staphylococcus aureus isolates from a patient with persistent bacteraemia and endocarditis

    Article • Clinical Microbiology and Infection, August 2008, Elsevier

    Dr Klaudia Kosowska-Shick, Professor Françoise Van Bambeke

  25. Polymorphism, genetic exchange and intragenic recombination of the aureolysin gene among Staphylococcus aureusstrains

    Article • BMC Microbiology, July 2008, Springer Science + Business Media

    Dr Klaudia Kosowska-Shick

  26. In Vitro Capability of Faropenem To Select for Resistant Mutants of Streptococcus pneumoniae and Haemophilus influenzae

    Article • Antimicrobial Agents and Chemotherapy, December 2007, ASM Journals

    Dr Klaudia Kosowska-Shick

  27. Capability of 11 Antipneumococcal Antibiotics To Select for Resistance by Multistep and Single-Step Methodologies

    Article • Antimicrobial Agents and Chemotherapy, September 2007, ASM Journals

    Dr Klaudia Kosowska-Shick

  28. Antistaphylococcal Activity of CG400549, a New Experimental FabI Inhibitor, Compared with That of Other Agents

    Article • Antimicrobial Agents and Chemotherapy, September 2007, ASM Journals

    Dr Klaudia Kosowska-Shick

  29. Characterization of a Daptomycin-Nonsusceptible Vancomycin-Intermediate Staphylococcus aureus Strain in a Patient with Endocarditis

    Article • Antimicrobial Agents and Chemotherapy, July 2007, ASM Journals

    Dr Klaudia Kosowska-Shick

  30. Multistep Resistance Selection and Postantibiotic-Effect Studies of the Antipneumococcal Activity of LBM415 Compared to Other Agents

    Article • Antimicrobial Agents and Chemotherapy, November 2006, ASM Journals

    Dr Klaudia Kosowska-Shick

  31. Activity of DX-619 Compared to Other Agents against Viridans Group Streptococci, Streptococcus bovis, and Cardiobacterium hominis

    Article • Antimicrobial Agents and Chemotherapy, October 2006, ASM Journals

    Dr Klaudia Kosowska-Shick

  32. Antipneumococcal Activity of DW-224a, a New Quinolone, Compared to Those of Eight Other Agents

    Article • Antimicrobial Agents and Chemotherapy, June 2006, ASM Journals

    Dr Klaudia Kosowska-Shick

  33. Single- and Multistep Resistance Selection Studies on the Activity of Retapamulin Compared to Other Agents against Staphylococcus aureus and Streptococcus pyogenes

    Article • Antimicrobial Agents and Chemotherapy, February 2006, ASM Journals

    Dr Klaudia Kosowska-Shick

  34. Comparison of Multiple-Locus Variable-Number Tandem-Repeat Analysis with Pulsed-Field Gel Electrophoresis, spa Typing, and Multilocus Sequence Typing for Clonal Characterization of Staphylococcus aureus Isolates

    Article • Journal of Clinical Microbiology, July 2005, ASM Journals

    Dr Klaudia Kosowska-Shick

  35. Macrolide Resistance in Streptococcus pneumoniae: Clonality and Mechanisms of Resistance in 24 Countries

    Article • Current Drug Targets - Infectious Disorders, September 2004, Bentham Science Publishers

    Dr Klaudia Kosowska-Shick, Dr Michael R Jacobs

  36. In vitro selection of resistance in haemophilus influenzae by 4 quinolones and 5 β-lactams

    Article • Diagnostic Microbiology and Infectious Disease, May 2004, Elsevier

    Dr Klaudia Kosowska-Shick

  37. Staphostatins resemble lipocalins, not cystatins in fold

    Article • Protein Science, October 2003, Wiley

    Dr Klaudia Kosowska-Shick

  38. Staphostatins: an expanding new group of proteinase inhibitors with a unique specificity for the regulation of staphopains, Staphylococcus spp. cysteine proteinases

    Article • Molecular Microbiology, July 2003, Wiley

    Dr Klaudia Kosowska-Shick